ROCHELLE B LAZARUS
CIK 1082206 · last filed 2026-04-03
ROCHELLE B LAZARUS is a corporate insider who has filed 135 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for BX, was dated Apr 3, 2026. Across all open-market trades the lifetime net is −$1.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $21.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$21.41M
5
135
-$1.70M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BX | Director | 62,657 | $122.79 | $7.69M | $0 | 14 | 2026-04-03 |
| OGN | Director | 633 | $13.44 | $8.5K | $0 | 5 | 2025-06-16 |
| MRK | Director | 6,351 | $119.05 | $756.1K | -$1.78M | 64 | 2020-04-02 |
| GE | Director | 38,621 | $335.30 | $12.95M | $79.0K | 46 | 2018-04-02 |
| Merck & Co., Inc. (MRKpB) Delisted | Director | 6,352 | — | — | $0 | 6 | 2010-08-06 |
Recent Filings
135 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-03 | BX | Grant (A) | +1,961 | $0 | EDGAR |
| 2025-07-10 | BX | Grant (A) | +1,334 | $0 | EDGAR |
| 2025-06-16 | OGN | Grant (A) | — | $0 | EDGAR |
| 2024-07-10 | BX | Grant (A) | +1,736 | $0 | EDGAR |
| 2024-06-11 | OGN | Grant (A) | — | $0 | EDGAR |
| 2023-07-11 | BX | Grant (A) | +2,283 | $0 | EDGAR |
| 2023-06-13 | OGN | Grant (A) | — | $0 | EDGAR |
| 2022-07-11 | BX | Grant (A) | +2,181 | $0 | EDGAR |
| 2022-06-14 | OGN | Grant (A) | — | $0 | EDGAR |
| 2021-07-13 | BX | Grant (A) | +2,123 | $0 | EDGAR |